Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
105.63
-0.86 (-0.81%)
Nov 5, 2024, 11:10 AM EST - Market open
Vaxcyte Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cost of Revenue | 75 | 75 | 23 | - | - | - | Upgrade
|
| Gross Profit | -75 | -75 | -23 | - | - | - | Upgrade
|
| Selling, General & Admin | 74.49 | 60.7 | 39.81 | 25.26 | 16.02 | 8.55 | Upgrade
|
| Research & Development | 427.66 | 332.34 | 169.45 | 78.41 | 73.56 | 45.61 | Upgrade
|
| Operating Expenses | 502.16 | 393.04 | 209.26 | 103.67 | 89.58 | 54.15 | Upgrade
|
| Operating Income | -577.16 | -468.04 | -232.26 | -103.67 | -89.58 | -54.15 | Upgrade
|
| Interest Expense | - | - | -0 | -0.01 | -0.01 | -0.04 | Upgrade
|
| Interest & Investment Income | 81.54 | 62.91 | 8.36 | 0.34 | 0.24 | 0.63 | Upgrade
|
| Currency Exchange Gain (Loss) | -3.79 | -1.9 | -1.47 | 1.67 | -2.35 | -0.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.17 | 4.77 | 1.93 | 1.59 | 2.48 | 0.24 | Upgrade
|
| EBT Excluding Unusual Items | -497.24 | -402.27 | -223.44 | -100.08 | -89.22 | -53.46 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.05 | - | - | 0 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.04 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 3.19 | Upgrade
|
| Pretax Income | -497.19 | -402.27 | -223.49 | -100.08 | -89.22 | -50.27 | Upgrade
|
| Net Income | -497.19 | -402.27 | -223.49 | -100.08 | -89.22 | -50.27 | Upgrade
|
| Net Income to Common | -497.19 | -402.27 | -223.49 | -100.08 | -89.22 | -50.27 | Upgrade
|
| Shares Outstanding (Basic) | 108 | 97 | 65 | 52 | 30 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 108 | 97 | 65 | 52 | 30 | 4 | Upgrade
|
| Shares Change (YoY) | 33.12% | 49.75% | 24.95% | 75.73% | 678.53% | 4.55% | Upgrade
|
| EPS (Basic) | -4.59 | -4.14 | -3.44 | -1.93 | -3.02 | -13.25 | Upgrade
|
| EPS (Diluted) | -4.59 | -4.14 | -3.44 | -1.93 | -3.02 | -13.25 | Upgrade
|
| Free Cash Flow | -582.34 | -364.67 | -176.45 | -127.95 | -47.78 | -48.34 | Upgrade
|
| Free Cash Flow Per Share | -5.38 | -3.75 | -2.72 | -2.46 | -1.62 | -12.74 | Upgrade
|
| EBITDA | -573.11 | -464.89 | -229.68 | -101.87 | -88.18 | -52.92 | Upgrade
|
| D&A For EBITDA | 4.05 | 3.16 | 2.58 | 1.8 | 1.41 | 1.23 | Upgrade
|
| EBIT | -577.16 | -468.04 | -232.26 | -103.67 | -89.58 | -54.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.